Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysis.

The most optimal antifungal agent for empiric treatment of invasive fungal diseases (IFDs) in febrile neutropenia is controversial. Our objective was evaluate the relative efficacy of antifungals for all-cause mortality, fungal infection-related mortality and treatment response in this population.